Berenberg Bank reaffirms Smith & Nephew’s “buy” rating: 4 takeaways

Berenberg Bank reaffirmed its “buy” rating on Smith & Nephew’s stock, according to a Financial Market News report.

Advertisement

Here are four takeaways:

 

1. Berenberg Bank currently has an $18.74 price target on the stock.

 

2. The company has a 50-day moving average of $1263.52 and a 200-day moving average of $1266.74.

 

3. Smith & Nephew has a one-year low of $1121.66 and a one-year high of $1356.65.

 

4. The stock’s market cap is $10.85 billion.

 

More articles on devices:
First Mercantile Trust buys additional Globus Medical shares: 5 points
5 things to know about Integra LifeSciences Holdings shares
Analysts expect Exactech shares to rise — 4 notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.